Phase 1b/2a Clinical Trial to Determine the Safety, Tolerability and Efficacy of TZ-161 in Spinal Cord Injury
NCT06677229
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
28
Enrollment
INDUSTRY
Sponsor class
Conditions
Acute Spinal Cord Injury (SCI)
Interventions
DRUG:
Eletriptan HBr 40 mg
Sponsor
Technophage, SA
Collaborators
[object Object]